Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million ...Middle East

HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...

Hence then, the article about innocan pharma reports full year 2024 results with revenues more than doubling to us 29 4 million was published today ( Tuesday 01/04/2025 - 12:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million )

Also on site :

• Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
• Golfer Masashi ‘Jumbo’ Ozaki dies at 78
• Russell Brand Prays on Instagram After New Charges of Rape and Sexual Assault